These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24524041)

  • 21. Longan fruit increase bone mineral density in zebrafish and ovariectomized rat by suppressing RANKL-induced osteoclast differentiation.
    Son Y; Lee EM; Lee DY; Lee JH; Oh S
    Phytomedicine; 2019 Jun; 59():152910. PubMed ID: 30978650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kalkitoxin Reduces Osteoclast Formation and Resorption and Protects against Inflammatory Bone Loss.
    Li L; Yang M; Shrestha SK; Kim H; Gerwick WH; Soh Y
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pentamidine Inhibits Titanium Particle-Induced Osteolysis
    Ihn HJ; Kim K; Cho HS; Park EK
    Tissue Eng Regen Med; 2019 Jun; 16(3):265-273. PubMed ID: 31205855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae.
    Palmqvist P; Persson E; Conaway HH; Lerner UH
    J Immunol; 2002 Sep; 169(6):3353-62. PubMed ID: 12218157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chlorogenic acid inhibits osteoclast differentiation and bone resorption by down-regulation of receptor activator of nuclear factor kappa-B ligand-induced nuclear factor of activated T cells c1 expression.
    Kwak SC; Lee C; Kim JY; Oh HM; So HS; Lee MS; Rho MC; Oh J
    Biol Pharm Bull; 2013; 36(11):1779-86. PubMed ID: 23985829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methylsulfonylmethane Inhibits RANKL-Induced Osteoclastogenesis in BMMs by Suppressing NF-κB and STAT3 Activities.
    Joung YH; Darvin P; Kang DY; Sp N; Byun HJ; Lee CH; Lee HK; Yang YM
    PLoS One; 2016; 11(7):e0159891. PubMed ID: 27447722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. alpha-Lipoic acid inhibits inflammatory bone resorption by suppressing prostaglandin E2 synthesis.
    Ha H; Lee JH; Kim HN; Kim HM; Kwak HB; Lee S; Kim HH; Lee ZH
    J Immunol; 2006 Jan; 176(1):111-7. PubMed ID: 16365401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.
    Udagawa N; Takahashi N; Jimi E; Matsuzaki K; Tsurukai T; Itoh K; Nakagawa N; Yasuda H; Goto M; Tsuda E; Higashio K; Gillespie MT; Martin TJ; Suda T
    Bone; 1999 Nov; 25(5):517-23. PubMed ID: 10574571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiation.
    Hyeon S; Lee H; Yang Y; Jeong W
    Free Radic Biol Med; 2013 Dec; 65():789-799. PubMed ID: 23954472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Palmatine attenuates osteoclast differentiation and function through inhibition of receptor activator of nuclear factor-κb ligand expression in osteoblast cells.
    Lee JW; Mase N; Yonezawa T; Seo HJ; Jeon WB; Cha BY; Nagai K; Woo JT
    Biol Pharm Bull; 2010; 33(10):1733-9. PubMed ID: 20930384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aspirin inhibits RANKL-induced osteoclast differentiation in dendritic cells by suppressing NF-κB and NFATc1 activation.
    Wu L; Luo Z; Liu Y; Jia L; Jiang Y; Du J; Guo L; Bai Y; Liu Y
    Stem Cell Res Ther; 2019 Dec; 10(1):375. PubMed ID: 31805984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PIAS3 negatively regulates RANKL-mediated osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblasts.
    Hikata T; Takaishi H; Takito J; Hakozaki A; Furukawa M; Uchikawa S; Kimura T; Okada Y; Matsumoto M; Yoshimura A; Nishimura R; Reddy SV; Asahara H; Toyama Y
    Blood; 2009 Mar; 113(10):2202-12. PubMed ID: 18952894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incorporation of RANKL promotes osteoclast formation and osteoclast activity on β-TCP ceramics.
    Choy J; Albers CE; Siebenrock KA; Dolder S; Hofstetter W; Klenke FM
    Bone; 2014 Dec; 69():80-8. PubMed ID: 25245204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Water extract of
    Shim KS; Kim T; Ha H; Lee CJ; Lee B; Kim HS; Park JH; Ma JY
    Integr Med Res; 2015 Jun; 4(2):102-111. PubMed ID: 28664115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenosine A(2A) receptor ligation inhibits osteoclast formation.
    Mediero A; Kara FM; Wilder T; Cronstein BN
    Am J Pathol; 2012 Feb; 180(2):775-86. PubMed ID: 22138579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand.
    Itoh K; Udagawa N; Katagiri T; Iemura S; Ueno N; Yasuda H; Higashio K; Quinn JM; Gillespie MT; Martin TJ; Suda T; Takahashi N
    Endocrinology; 2001 Aug; 142(8):3656-62. PubMed ID: 11459815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracellular calcium and protein kinase C mediate expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in osteoblasts.
    Takami M; Takahashi N; Udagawa N; Miyaura C; Suda K; Woo JT; Martin TJ; Nagai K; Suda T
    Endocrinology; 2000 Dec; 141(12):4711-9. PubMed ID: 11108286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of ferric ion on the differentiation of osteoclast and bone resorption].
    Jia P; He YF; Gao C; Du HB; Hu ZY; Feng XQ; Li BY; Zhang ZL; Xu YJ; Lin H
    Zhonghua Yi Xue Za Zhi; 2012 Aug; 92(31):2214-8. PubMed ID: 23158430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary human bone marrow adipocytes support TNF-α-induced osteoclast differentiation and function through RANKL expression.
    Goto H; Hozumi A; Osaki M; Fukushima T; Sakamoto K; Yonekura A; Tomita M; Furukawa K; Shindo H; Baba H
    Cytokine; 2011 Dec; 56(3):662-8. PubMed ID: 21963155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-4 inhibits TNF-α-mediated osteoclast formation by inhibition of RANKL expression in TNF-α-activated stromal cells and direct inhibition of TNF-α-activated osteoclast precursors via a T-cell-independent mechanism in vivo.
    Fujii T; Kitaura H; Kimura K; Hakami ZW; Takano-Yamamoto T
    Bone; 2012 Oct; 51(4):771-80. PubMed ID: 22776139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.